Showing results (341-350 of 364) with videos related to

Sort By:
Pageof 37
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 23, 2022
Acute Administration of the GLP-1 Receptor Agonist Lixisenatide Diminishes Postprandial Insulin Secretion in Healthy Subjects But Not in Type 2 Diabetes, Associated with Slowing of Gastric EmptyingChinmay S Marathe, Hung Pham, Tongzhi Wu, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2009
Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemiaAdam M Deane, Nam Q Nguyen, Julie E Stevens, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 11, 2006
The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposedTanya J Little, Selena Doran, James H Meyer, et al.
Diabetes|October 4, 2013
Comparative effects of prolonged and intermittent stimulation of the glucagon-like peptide 1 receptor on gastric emptying and glycemiaMahesh M Umapathysivam, Michael Y Lee, Karen L Jones, et al.
Igie : Innovation, Investigation and Insights|February 6, 2026
Outcomes of phosphorus-32 microparticle intratumoral implantation added to chemotherapy in patients with metastatic pancreatic adenocarcinomaAmanda Huoy Wen Lim, Nimit Singhal, Dylan Bartholomeusz, et al.
Diabetes|October 17, 2015
The Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled TrialSony S Thazhath, Chinmay S Marathe, Tongzhi Wu, et al.
Diabetes Care|May 31, 2020
Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled TrialChristopher K Rayner, Linda E Watson, Liza K Phillips, et al.
Critical Care Medicine|August 22, 2013
The effects of critical illness on intestinal glucose sensing, transporters, and absorptionAdam M Deane, Chris K Rayner, Alex Keeshan, et al.
Acta Anaesthesiologica Scandinavica|December 15, 2016
Occult upper gastrointestinal mucosal abnormalities in critically ill patientsC Ovenden, M P Plummer, S Selvanderan, et al.
Diabetes, Obesity & Metabolism|January 7, 2020
Exenatide once weekly slows gastric emptying of solids and liquids in healthy, overweight people at steady-state concentrationsKaren L Jones, Lian Q Huynh, Seva Hatzinikolas, et al.
Pageof 37